Effects of bone remodelling on calcium mass transfer during haemodialysis

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1244-1251

  Karohl, Cristina ^a,b   De Paiva Paschoal, Juliana ^a   De Castro, Manuel Carlos Martins ^a   Elias, Rosilene Motta ^a   Abensur, Hugo ^a   Romão, João Egídio ^a   Passlick Deetjen, Jutta ^c,d   Jorgetti, Vanda ^a   Moysés, Rosa Maria Affonso ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Fresenius Medical Care ^*  (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Calcium balance; Calcium kinetic; Hemodialysis; Parathormone; Renal osteodystrophy

Indexed keywords

CALCITRIOL; CALCIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER;

ADULT; AGED; ARTICLE; BONE REMODELING; CALCIUM BALANCE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE REMODELING; CALCIUM; DIALYSIS SOLUTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATES; RENAL DIALYSIS; YOUNG ADULT;

EID: 77950275096     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp597     Document Type: Article

References (30)

1. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
2. London GM, Guerin AP, Marchais F, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
3. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187
4. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953
5. Johnson WJ, Goldsmith RS, Beabout JW, et al. Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysis. Am J Med 1974; 56: 827-832
6. Johnson WJ. Optimum dialysate calcium concentration during maintenance hemodialysis. Nephron 1976; 17: 241-258
7. Slatopolsky E, Weerts C, Lopez-Hilker S, et al. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 1986; 315: 157-161
8. Slatopolsky E, Weerts C, Norwood K, et al. Long-term effects of calcium carbonate and 2.5mEq/L calcium dialysate on mineral metabolism. Kidney Int 1989; 36: 897-903
9. Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
10. Eknoyan G, Levin A, Levin NW. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: 1-201
11. Hou SH, Zhao J, Ellman CF, et al. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 1991; 18: 217-224
12. Fernandez E, Borras M, Pais B, et al. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc Nephrol 1995; 6: 132-135
13. Argiles A, Kerr PG, Canaud B, et al. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int 1993; 43: 630-640
14. Hamano T, Oseto S, Fujji N, et al. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients. Bone 2005; 36: 909-916
15. Daugirdas JT, Van Stone JC. Physiologic principles and urea kinetic modeling. Handbook of Dialysis. Philadelphia: Lippincott Williams & Wilkins, 2001; 3rd ed; 15-45
16. Sigrist M, McIntyre CW. Calcium exposure and removal in chronic hemodialysis patients. J Ren Nutr 2006; 16: 41-46
17. Albalate M, Piedra C, Fernandez C, et al. Association between phosphate removal and markers of bone turnover in hemodialysis patients. Nephrol Dial Transplant 2006; 21: 1626-1632
18. Heaney RP. How does bone support calcium homeostasis?. Bone 2003; 33: 264-268
19. Parffit AM. Misconceptions (3): calcium leaves bone only by resorp-tion and enters only by formation. Bone 2003; 33: 259-263
20. Talmage RV, Matthews JL, Mobley HT, et al. Calcium homeostasis and bone surface proteins, a postulated vital process for plasma calcium control. J Musculoskelet Neuronal Interact 2003; 3: 194-200
21. Marenzana M, Shipley AM, Squitiero P, et al. Bone as an ion exchange organ: evidence for instantaneous cell-dependent calcium efflux from bone not due to resorption. Bone 2005; 37: 545-554
22. Talmage RV, Talmage DW. Calcium homeostasis: solving the solubility problem. J Musculoskelet Neuronal Interact 2006; 6: 402-407
23. Ureña P, de Vernejoul MC. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 1999; 55: 2141-2156
24. Yu S, Franceschi RT, Luo M, et al. Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for Osteocalcin gene expression. Endocrinology 2008; 149: 1960-1968
25. Gotch F, Kotanko P, Handelman G, et al. A kinetic model of calcium mass balance during dialysis therapy. Blood Purif 2007; 25: 139-149
26. Saisu T, Wakabayashi Y, Yamada K, et al. Effect of low-calcium he-modialysate on bone metabolism. J Bone Miner Metab 2000; 18: 57-62
27. Sherrard DJ, Hercz G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int 1993; 43: 436-442
28. Wang M, Hercz G, Sherrard DJ, et al. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 1995; 26: 836-844
29. Martin K, Olgaard K. Diagnosis, assessment and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004; 43: 558-565
30. Barreto FC, Barreto DV, Moysés RM, et al. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemo-dialysis patients. Kidney Int 2008; 73: 771-777